Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65

Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65

The authors originally published this article under the incorrect license type; this has now been corrected and is published under the CC-BY license.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gene therapy 2018-09, Vol.25 (6), p.450-450
Hauptverfasser: Georgiadis, A., Duran, Y., Ribeiro, J., Abelleira-Hervas, L., Robbie, S. J., Sünkel-Laing, B., Fourali, S., Gonzalez-Cordero, A., Cristante, E., Michaelides, M., Bainbridge, J. W. B., Smith, A. J., Ali, R. R.
Format: Artikel
Sprache:eng
Schlagworte:
631/1647/2300/1514
Biomedical and Life Sciences
Biomedicine
Cell Biology
Correction
Gene Expression
Gene Therapy
Human Genetics
Nanotechnology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The authors originally published this article under the incorrect license type; this has now been corrected and is published under the CC-BY license.
ISSN:0969-7128
1476-5462
DOI:10.1038/s41434-018-0031-x